Pancreatic cancer is a malignancy with an extremely poor prognosis. Chronic pancreatitis is a well-known risk factor for pancreatic cancer. Inflammation is thought to influence carcinogenesis through DNA damage and activation of intracellular signaling pathways. Many transcription factors and signaling pathways co-operate to determine and maintain cell identity at each phase of pancreatic organogenesis and cell differentiation. Recent studies have shown that carcinogenesis is promoted through the suppression of transcription factors related to differentiation. Pancreatitis also demonstrates transcriptional changes, suggesting that multifactorial epigenetic changes lead to impaired differentiation. Taken together, these factors may constitute an important framework for pancreatic carcinogenesis. In this review, we discuss the role of inflammation and de-differentiation in the development of pancreatic cancer, as well as the future of novel therapeutic applications. World Journal of Clinical Cases W J C C carcinogenesis is promoted by reprogramming factors and by suppressing transcription factors related to acinar cell differentiation. Pancreatitis also shows such transcriptional changes, suggesting that epigenetic changes by several causes leading to the impaired differentiation may constitute an important framework for pancreatic carcinogenesis. New diagnostic, preventive and/or treatment strategies based on the findings described in this review are expected to be clinically applied in the near future.
INTRODUCTION
The worldwide incidence of pancreatic cancer is ap proximately 330000 cases in 2012, with trends indi cating that rates are higher in men and in developed countries. The number of deaths due to pancreatic cancer are also estimated to be approximately 330000 people a year; it ranks 11th in cancerrelated deaths [1, 2] . The mean survival time is 19 mo and the 5year su rvival rate is 5% or less; these figures indicate that pancreatic cancer has one of the worst prognoses across all forms of malignancy [2, 3] . The early stages of pancreatic cancer are almost always asymptomatic. As a result, by the time symptoms become apparent, the disease is already at a very advanced stage. Because the 5year survival rates of stage Ⅰ and Ⅳ pancreatic cancers are 43% and 7.7% respectively, early diagnosis and treatment are especially crucial to improve the overall prognosis of the disease.
One option, to aid in the earlier diagnosis of pan creatic cancer, is to elucidate more thoroughly the mechanism of carcinogenesis and identify highrisk gro ups to follow carefully. Wellknown risk factors include smoking, obesity, diabetes, and chronic pancreatitis [4] . In particular, the risk of pancreatic cancer in patients with chronic pancreatitis is 13.3 times greater than that of healthy controls, suggesting that inflammation is deeply involved in the pathogenesis of pancreatic cancer [5, 6] . It is well known that the KRAS mutation and mutational inactivation of the CDKN2A, TP53, and SMAD4 tumor suppressors play important roles in the development of pancreatic cancer [4, 79] . Furthermore, recent studies have shown that carcinogenesis is pro moted by reprogramming factors and by suppression of transcription factors related to differentiation [10, 11] . Interestingly, pancreatitis also shows the above trans criptional changes, suggesting that multifactorial epige netic changes that result in impaired differentiation have an important role in pancreatic carcinogenesis.
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In this review, we will discuss the mechanisms of pancreatic carcinogenesis from the perspective of pancreatic inflammation and cell differentiation.
INFLAMMATION AND PANCREATIC

CARCINOGENESIS
In 1863, Rudolph Virchow first reported inflamma tory cells in cancer tissues and hypothesized that inflammation promoted carcinogenesis [12] . In 1915, Yamagiwa induced skin cancer on the ears of rabbits by repeatedly painting them with coal tar, and expe rimentally revealed a case of carcinogenesis due to infla mmation [13] . Furthermore, several cancers are known to be epidemiologically related to inflammatory diseases. For example, Helicobacter pylorirelated gastritis patients have a 2.6fold increased risk of gastric cancer [14] . Viral hepatitis and inflammatory bowel disease are risk factors for liver cancer and colon cancer, respectively. Previous epidemiological studies have demonstrated that non steroidal antiinflammatory drugs such as aspirin, lowers the overall risk of colon cancer [15, 16] . Taken together, these results suggest that inflammation is frequently associated with carcinogenesis.
Chronic pancreatitis is a risk factor for pancreatic cancer [6] . Patients with hereditary pancreatitis, a rare cause of chronic pancreatitis and a strong risk for pancreatic cancer (49% of the patients develop pan creatic cancer by age 75 years), suffer from recurrent pancreatitis with pancreatic exocrine insufficiency and diabetes mellitus from a young age [17] . Mutations of the cationic trypsinogen (PRSS1) and serine protease inhibitor Kazal type 1 (SPINK1) genes cause heredi tary pancreatitis [18, 19] . Because the risk of developing pancreatic cancer does not change with the presence or absence of PRSS1 or SPINK1 gene mutations, it is unlikely that the gene itself functions as an oncogene or tumorsuppressor gene [19, 20] . The increased carcinogenic risk in hereditary pancreatitis patients is presumed to be carcinogenesis due to prolonged inflammation.
Notably, Bailey et al [21] conducted unsupervised clustering of pancreatic cancer RNA sequencing data, and they classified pancreatic cancers into four subtypes: Squamous, pancreatic progenitor, immunogenic, and aberrantly differentiated endocrine exocrine. Each subtype differently expresses unique transcription fac tors and downstream targets, which are important in line age specification and differentiation during pancreas development. Among them, the immunogenic subtype is associated with a significant immune infiltrate [21] , which may be associated with pancreatitis and carcinogenesis.
The relationship between pancreatic cancer and inflammation has also been explored in experiments using genetically engineered mice. When Kras mutations were introduced during the embryonic stage in mice, pancreatic intraepithelial neoplasia (PanIN) formation was promoted while pancreatic cancer developed at a lower frequency [22] . The introduction of Kras mutations December 6, 2018|Volume 6|Issue 15| alone induced pancreatic cancer development over 1 year; however, when Trp53 and Cdkn2a defects were introduced, it only took 7 and 18 wk, respectively, to develop pancreatic cancer [23] . Furthermore, when pan creatitis was induced by administering caerulein in Kras mutant mice, carcinogenesis occurred at 12 wk [24] . These results demonstrated that some secondary ab normalities in Krasmutated mice are necessary for rapid progression to invasive cancer, and that infla mmation promotes carcinogenesis in conjunction with Kras mutations.
DNA damage caused by inflammation may contri bute to carcinogenesis (Figure 1 ) [25] . Inflammatory cyto kines produce reactive oxygen species, which randomly oxidize DNA to cause genetic mutation [26] . NO, induced by inflammation, also inhibits DNA repair enzymes to promote mutations [27] . In fact, the duration of chronic pancreatitis correlates positively with the incidence of KRAS mutations, suggesting that DNA damage accumulates due to the persistence of inflammation, promoting further carcinogenesis [28] . Although random genetic mutations caused by inflammation may contribute to carcinogenesis, work done by Guerra et al [29] suggests an alternative role of inflammation in the development of carcinogenesis. Guerra et al [29] used a Cre Tetoff system to control the expression of mutant Kras in mice. When mutant KRas was expressed during the embryonic stage, PanIN was formed at 13 mo. However, when mutant KRas was expressed in adult mice 2 mo after birth, PanIN was not formed. Furthermore, even when Cdkn2a or Trp53 gene deficiencies were simultaneously introduced into adult mutant Kras mice, PanIN did not develop [29] . These results suggest that the carcinogenic potential through genetic mutation differs between the embryonic and adult stages in mice. Moreover, when pancreatitis was induced by administering caerulein to adult mutant Kras mice, PanIN developed and rapidly progressed to pancreatic cancer [30] . However, PanIN did not de velop after deletion of Cdkn2a or Trp53 in adult mice accompanied with caerulein pancreatitis. From these results, mutant Kras and inflammation are necessary components of pancreatic carcinogenesis in adult mice, with inflammation contributing to carcinogenesis by means other than the introduction of specific gene mutations as a result of DNA damage. Recent studies revealing the association of various signaling pathways and microenvironments with inflammation and pancre atic carcinogenesis may support this concept.
CELL-AUTONOMOUS INTRACELLULAR SIGNALING PATHWAYS IN PANCREATIC INFLAMMATION AND CARCINOGENESIS
Nuclear factor κB (NFκB) is involved not only in infla mmation but also in cell differentiation and proliferation, both of which are activated in pancreatic cancer [31, 32] . Mutant KRas is known to activate interleukin1alpha (IL 1α) via AP1. IL1α polyubiquitinates tumor necrosis fa December 6, 2018|Volume 6|Issue 15|
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ctor receptorassociated factor 6 and activates IKK2/β, which activates NFκB. NFκB subsequently upregulates IL-1α and p62 transcription, which in turn reactivates NFκB in a positive feedback loop [33] . Because activated NFκB activates KRas, another positive feedback loop is generated, resulting in sustained KRas activity which may promote pancreatic cancer development [34] . Additionally, Toll like receptor 4 (TLR4) and TLR7 are upregulated within the pancreatic cancer micro environment [35, 36] . TLRs are receptors that recognize pathogenassociated molecular patterns and diverse byproducts of inflammation and cellular injury. Acti vated TLRs induce the activation of NFκB pathway within acinar cells, which may further promote the deve lopment of pancreatic cancer.
NON CELL-AUTONOMOUS INTRACELLULAR SIGNALING PATHWAYS IN PANCREATIC INFLAMMATION AND CARCINOGENESIS
The IL6 / STAT3 pathway is also involved in pancreatic cancer and inflammation [37] . While caeruleininduced pancreatitis transiently activates STAT3, prolonged activity and PanIN development were both observed in Kras mutant mice [38] . In these mice, pancreatic Kras mutant epithelial cells recruited macrophages, which secreted IL6, result in the STAT3 activation in epithelial cells and formation of PanIN. Conversely, inactivation of IL6 transsignaling or inhibition of STAT3 resulted in decreased PanIN formation [39] . Various studies have revealed that macrophages play an important role in pancreatitis, and are likely to be related to pancreatic carcinogenesis [40] . As mention ed above, macrophages secrete IL6 and activate the STAT3 signaling pathway to promote pancreatic car cinogenesis. In addition, macrophages are observed around acinar ductal metaplasia (ADM) lesions, which are precancerous lesions formed in response to pan creatitis. They secrete inflammatory cytokines such as TNFα, and the chemokine regulated upon activation of normal T cell expressed and presumably secreted (RANTES). They also promote ADM formation through activation of NFκB and matrix metalloproteinase9 [41, 42] . Macrophages that migrate around ADM and PanIN are polarized dominantly from M1 to M2 by stimulation of IL13. M2 macrophages secrete CCL2 and IL1ra, which activate the ERK signaling pathway and promote the growth of PanIN [43] . Th17 is associated with many inflammatory con ditions, such as inflammatory bowel diseases. In the pancreas, the NODlike receptor family pyrin domain containing 3 (NLRP3) inflammasome is also activated in pancreatitis [44] . Macrophages expressing NLRP3 ina ctivate cytotoxic CD8+ T cells through the activation of Th17 and regulatory T cells, which also contribute to the promotion of pancreatic cancer development [45] .
PANCREATIC ORGANOGENESIS AND DIFFERENTIATION
The Guerra et al [29] study demonstrated that KRAS gene mutations induce PanIN formation in the embryonic, but not the adult stage. From these results, cell differentiation status at the embryonic or adult stage may control organ carcinogenesis. Research on the inflammation and differentiation of pancreatic cells has been increasing in recent years, and elucidation of pan creatic embryology on a cellular level would provide great understanding to pancreatic cancer development. Pancreatic development begins with the evagina tion of dorsal mesenchyme of foregut endoderm on embryonic day 26 (E26) in humans and E9.5 in mice [4648] ( Figure 2) . The ventral pancreatic bud emerges at 6 d in humans and at 12 h in mice after the appearance of the dorsal pancreatic bud. Branching begins immediately after evagination. Stalk elongation and gut rotation occur on the ventral and dorsal side, while fusion of the ventral and dorsal pancreas occurs during E12 to E13 in mice and E37 to E42 in humans. During E1314 in mice, there is a dramatic increase in endocrine cells, particularly βcells, known as "secondary transition". Similarly, aci nar cells develop and acinar enzyme gene expression increases. After E15 in mice, the destiny of pancreatic cells is determined.
Pancreatic tissue consists of acinar, duct, and endocrine cells. Lineage tracing using CreERT mice revealed that multipotent progenitor cells differentiate into respective cell populations [49] . Multipotent progenitor cells coexpress homeobox protein PDX1, Srybox pro tein SOX9, and basic helixloophelix (bHLH) protein PTF1A. As differentiation continues, the expression of PDX1, SOX9 and PTF1A are restricted in endocrine, duct, and acinar cells respectively. During early branching morphogenesis, the branch tip is composed of PDX1, PTF1A, and Cpa1 positive multipotent progenitor cells that can differentiate into all three type of cells; however, cells in the tip area lose their multipotency and change into proacinar cells after E14 [50] . The trunk region is composed of bipotent progenitor cells that can differentiate into either duct or endocrine cells [51] . Some of these cells express neurogenin 3 (NGN3) and will differentiate further into endocrine cells [52] . Various transcription factors and signaling pathways are involved in acinar cell development. NR5A2 is a member of the nuclear hormone receptor family, and is responsible for pancreatic exocrine secretion in the mature pancreas [53] . NR5A2 regulates the various stages of development and is required for OCT4 expression in the epiblast [54] . It is also required for gastrulation and acinar cell maturation during secondary transition [55, 56] . Since there is decreased expression of pancreasre lated transcription factors during secondary transition, NR5A2 is thought to regulate pancreatic differentiation in cooperation with other transcription factors at this stage [56] .
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MIST1 is a bHLH transcription factor, highly expre ssed in acinar cells, as well as the stomach, prostate, and seminal vesicles [57] . Mice with Mist1 gene knockout developed highly disorganized acinar cells with impair ed exocytosis [58] . Furthermore, ADM formation and sus ceptibility to caerulein pancreatitis were increased in these mice [59] . MIST1 is thought to be required for the maintenance of acinar cell identity.
The Wnt/β catenin signaling pathway is necessary for differentiation of acinar cells. Pancreatic hypoplasia was observed in β-catenin knockout mice [60] . Furthermore, acinar cell proliferation was promoted by deficiencies in the Apc gene, which has endogenous βcatenin inhibitory activity. Because this abnormal proliferation stops when c-myc is deleted, c-myc is considered to be an important downstream component of the Wnt/β catenin pathway [61] . The Hippo signaling pathway has been associated with pancreatic development. Deletion of the core Hippo kinase genes Mst1 and Mst2 induced pancreatic hypoplasia via YAP, the downstream mediator. In terestingly, in Mst1 and Mst2 double knockout mice, expression levels of MIST1, PTF1A, and NR5A2 were equivalent to those seen in wild type mice, with normal pancreatic sizes at birth. However, after 1 mo, the acinar cells changed to ductlike cells while the overall size of the pancreas was approximately half that of wild type mice. This suggests that the Hippo signaling pathway is necessary to maintain acinar cell identity and pancreas size after birth in mice [62] . The Notch signaling pathway is also indirectly related to acinar cell differentiation via lateral inhibition. NGN3 is a transcription factor that promotes differentiation to endocrine cells. Cells expressing NGN3 upregulate the expression of DLL1, which is a Notch ligand. DLL1 binds to the Notch receptor of surrounding cells and activates the Notch signaling pathway, thereby upregulating HES1 expression. HES1 inhibits NGN3 and suppresses endocrine cell proliferation. HES1 also maintains the expression level of PTF1A in multipotent progenitor cells and is thought to contribute to multipotent progenitor cell proliferation [63] .
PANCREATIC CELL DE-DIFFERENTIATION, INFLAMMATION, AND CARCINOGENESIS
As described above, pancreatic cell differentiation and their identities are maintained by the cooperation of various transcription factors and signaling pathways. However, recent research has revealed that differen tiated pancreatic cells show plasticity under specific circumstances. Acinar cells transdifferentiate or de differentiate into duct cells and endocrine cells after pancreatic duct ligation. During this change, cells ex press SOX9 and HNF1β multipotency factors [64, 65] . The conversion from an acinar cell to embryonic progeni tor phenotype that exhibits ductal markers, is called ADM. ADM is thought to be a reversible process and is frequently observed in pancreatic inflammation and injury. However, it becomes irreversible when combined with a Kras mutation. This alteration results in a lesion that is considered a precancerous stage of pancreatic cancer [66, 67] . Epigenetic factors play crucial roles in differentiation and carcinogenesis. A recent study showed that Brg1, a catalytic ATPase subunit of the SWI/SNF chromatin remodeling complex, is inactivated in approximately 10% of pancreatic cancer [68] . Brg1 binds to the SOX9 promoter and regulates the expression of SOX9. Acinar cellspecific deletion of Brg1 attenuates ADM/PanIN formation in Kras mutant mice [69] . NR5A2 suppression and forced expression of SOX9 or PDX1 can induce ADM [11, 7072] . These results suggest that transcriptional changes that cause the loss of aci nar cell identity promote ADM formation. Interestingly, although the pancreatic tissues of Nr5a2 +/ mice are histologically normal, transcriptome analyses of Nr5a2 +/ mice show inflammasome upregulation. In humans, simi lar transcriptomic changes occur in the pancreas with low levels of NR5A2 expression. Furthermore, NR5A2 is relocated from the promoters of differentiationspecific genes to the promoters of inflammationrelated genes. AP1 is upregulated in these mice and the deletion of Jun results in the downregulation of AP1 and NR5A2 binding to AP1 and inflammatory gene promoters [73] . In another study, temporal activation of repro gramming factors (Oct3/4, Sox2, Klf4, c-Myc) in the pancreas of Kras mutant mice promoted ADM forma tion and pancreatic cancer [10] (Figure 3) 
FUTURE PERSPECTIVES
A growing body of research in pancreatic carcinogen esis demonstrates that the loss of acinar cell identity caused by the suppression of transcriptional networks by reprogramming factors plays a crucial role in ADM formation. In addition, Kras mutation and epigen etic regulation play important roles in pancreatic car cinogenesis. Furthermore, inflammation induces an intracellular transcriptional state similar to the de differentiated state of pancreatic cells, implying that inflammation, cell differentiation, and carcinogenesis are very closely related. Some questions remain to be resolved. Inflammation may induce not only dedifferentiation but also stem cell damage and impaired differentiation, and sub sequently cause carcinogenesis. Further research is needed to determine the origin of pancreatic cancer. There is a strong association between chronic pan creatitis and pancreatic cancer. However, only 1.34% of pancreatic cancers are thought to be caused by chronic pancreatitis [74] . Furthermore, pancreatic can cer concomitant with intraductal papillary mucinous neoplasm, a premalignant lesion of pancreatic cancer, is not associated with pancreatitis or pancreatic atro phy [75] . However, these epidemiological and patholo gical data do not completely deny the connection bet ween carcinogenesis and inflammation. One possible explanation is that proinflammatory states may exist in the absence of histologically observed pancreatitis [73] . Further studies are required to clarify the inflammation like changes in "inflammationabsent" preneoplastic pancreatic lesions. This may subsequently allow the identification of highrisk patients.
Many novel therapeutic strategies for pancreatic cancer are aimed at reprogramming pancreatic cancer cells to behave like normal pancreatic cells [76] . For exa mple, PD 325901 inhibits MEK1/2 and induces PanIN December 6, 2018|Volume 6|Issue 15| Seimiya T et al . Inflammation and de-differentiation in pancreatic carcinogenesis redifferentiation into acinar cells [77] . Another study has shown that the overexpression of bHLH transcription factors E47 and PTF1A resulted in increased acinar cell gene expression, suppressing cancer proliferation [78, 79] . It is highly expected that in the near future, new dia gnostic and/or treatment strategies based on the fin dings described in this review will be clinically applied, improving the prognosis of patients with pancreatic cancer. 
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